Abstract
Evaluation of the Occurrence and Risk Factors for Spontaneous Cytomegalovirus Clearance after Low Level Reactivation Using a Pre-Emptive Treatment Threshold of 4,000 IU/Ml in Seropositive Allogeneic Hematopoietic Cell Transplant Recipients Receiving Letermovir Prophylaxis
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
